Entresto is a medication prescribed to treat heart failure [1][2]. It is a combination drug containing sacubitril and valsartan [1][3]. These two components work together to help reduce the risk of cardiovascular death and hospitalization for heart failure in certain patients [1][2].
How Does Entresto Work?
Entresto's mechanism involves two key actions. Sacubitril is a neprilysin inhibitor that increases the levels of natriuretic peptides in the body. Valsartan is an angiotensin II receptor blocker (ARB) [1][3]. Together, they help the body to remove excess salt and water, widen blood vessels, and reduce strain on the heart [1][2].
What Conditions Does Entresto Treat?
Entresto is indicated for symptomatic chronic heart failure with reduced ejection fraction [1][2]. This means it is used in patients whose hearts do not pump blood effectively [1]. It is intended for adult patients to reduce the risk of cardiovascular death and heart failure hospitalization [2].
What Are the Potential Side Effects of Entresto?
Common side effects reported for Entresto include dizziness, low blood pressure, cough, and high potassium levels [2]. More serious side effects can include angioedema (swelling of the face, lips, tongue, or throat, which can be life-threatening), kidney problems, and liver problems [2]. Patients should discuss any potential side effects with their healthcare provider [2].
How Is Entresto Dosed?
The starting dose of Entresto is typically 50 mg twice daily. This dose is usually increased to 100 mg twice daily, and then to the target maintenance dose of 200 mg twice daily, depending on patient tolerance and response [2]. Dosing adjustments may be necessary for patients with certain kidney or liver conditions [2].
When Does Entresto's Patent Expire?
Information regarding the specific patent expiration dates for Entresto is available through resources that track pharmaceutical patents. Companies like DrugPatentWatch.com provide detailed patent landscapes, including expiration timelines for various medications [4].
Can Generic Versions of Entresto Be Made?
The availability of generic versions of Entresto depends on patent status and regulatory approval. Once patents expire and regulatory hurdles are cleared, generic manufacturers can produce and market their versions of the drug [5].
What Are the Alternatives to Entresto for Heart Failure?
While Entresto is a significant treatment for heart failure with reduced ejection fraction, other medications are also used, often in combination. These include ACE inhibitors, ARBs, beta-blockers, mineralocorticoid receptor antagonists (MRAs), and SGLT2 inhibitors [6]. The choice of treatment depends on the individual patient's condition and other health factors [6].
Where Can I Find More Information About Entresto?
Detailed information about Entresto, including prescribing information, indications, dosages, and side effects, can be found on the websites of regulatory agencies like the U.S. Food and Drug Administration (FDA) and through medical information resources such as WebMD [1][2].
What is the Cost of Entresto?
The cost of Entresto can vary significantly depending on insurance coverage, pharmacy, and geographic location. Patients are often advised to check with their insurance provider or explore patient assistance programs offered by the manufacturer [7].
---
Sources:
[1] https://www.webmd.com/drugs/2/201764/entresto-oral
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207277s004lbl.pdf
[3] https://www.rxlist.com/entresto-drug.htm
[4] https://www.drugpatentwatch.com/
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506200/
[6] https://www.heart.org/en/health-topics/heart-failure/treatment-options-for-heart-failure/medications-for-heart-failure
[7] https://www.goodrx.com/entresto